Applied DNA Earnings Estimate
| APDN Stock | USD 5.28 0.08 1.54% |
Applied DNA Revenue Breakdown by Earning Segment
By analyzing Applied DNA's earnings estimates, investors can diagnose different trends across Applied DNA's analyst sentiment over time as well as compare current estimates against different timeframes. As of the 23rd of July 2025, Gross Profit is likely to drop to about 1.1 M. In addition to that, Pretax Profit Margin is likely to drop to -1.95Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied DNA Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
Applied DNA Earnings Estimation Breakdown
The calculation of Applied DNA's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Applied DNA is estimated to be -37.5 with the future projection ranging from a low of -37.5 to a high of -37.5. Please be aware that this consensus of annual earnings estimates for Applied DNA Sciences is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-37.5 Lowest | Expected EPS | -37.5 Highest |
Applied DNA Earnings Projection Consensus
Suppose the current estimates of Applied DNA's value are higher than the current market price of the Applied DNA stock. In this case, investors may conclude that Applied DNA is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Applied DNA's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 30th of June 2025 | Current EPS (TTM) | |
| 1 | 56.73% | -15.3924 | -37.5 | 3730.95 |
Applied DNA Earnings History
Earnings estimate consensus by Applied DNA Sciences analysts from Wall Street is used by the market to judge Applied DNA's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Applied DNA's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.Applied DNA Quarterly Gross Profit |
|
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Applied DNA's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Applied DNA Earnings per Share Projection vs Actual
Actual Earning per Share of Applied DNA refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Applied DNA Sciences predict the company's earnings will be in the future. The higher the earnings per share of Applied DNA, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Applied DNA Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Applied DNA, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Applied DNA should always be considered in relation to other companies to make a more educated investment decision.Applied Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Applied DNA's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-05-08 | 2025-03-31 | -3 | -15.3924 | -12.3924 | 413 | ||
2025-02-06 | 2024-12-31 | -0.33 | -0.5616 | -0.2316 | 70 | ||
2024-12-05 | 2024-09-30 | -0.35 | -0.307 | 0.043 | 12 | ||
2024-08-08 | 2024-06-30 | -0.35 | 0.47 | 0.82 | 234 | ||
2024-05-10 | 2024-03-31 | -4.5 | -5.31 | -0.81 | 18 | ||
2024-02-08 | 2023-12-31 | -0.31 | -0.09 | 0.22 | 70 | ||
2023-12-07 | 2023-09-30 | -0.27 | -0.26 | 0.01 | 3 | ||
2023-08-10 | 2023-06-30 | -0.24 | -0.24 | 0.0 | 0 | ||
2023-05-11 | 2023-03-31 | -0.2 | 0.05 | 0.25 | 125 | ||
2023-02-09 | 2022-12-31 | -0.29 | -0.3 | -0.01 | 3 | ||
2022-12-14 | 2022-09-30 | -0.26 | -0.01 | 0.25 | 96 | ||
2022-08-11 | 2022-06-30 | -0.35 | -0.13 | 0.22 | 62 | ||
2022-05-12 | 2022-03-31 | -0.33 | -0.23 | 0.1 | 30 | ||
2022-02-10 | 2021-12-31 | -0.27 | -0.63 | -0.36 | 133 | ||
2021-12-09 | 2021-09-30 | -0.37 | -0.6 | -0.23 | 62 | ||
2021-08-12 | 2021-06-30 | -0.26 | -0.46 | -0.2 | 76 | ||
2021-05-13 | 2021-03-31 | -0.21 | -0.33 | -0.12 | 57 | ||
2021-02-11 | 2020-12-31 | -0.54 | -0.56 | -0.02 | 3 | ||
2020-12-17 | 2020-09-30 | -0.52 | -0.78 | -0.26 | 50 | ||
2020-08-06 | 2020-06-30 | -0.67 | -0.72 | -0.05 | 7 | ||
2020-05-14 | 2020-03-31 | -0.77 | -0.79 | -0.02 | 2 | ||
2020-02-06 | 2019-12-31 | -1.24 | -1.12 | 0.12 | 9 | ||
2019-12-12 | 2019-09-30 | -1.26 | -2.63 | -1.37 | 108 | ||
2019-08-13 | 2019-06-30 | -1 | -1.6 | -0.6 | 60 | ||
2019-05-09 | 2019-03-31 | -3.6 | -3.2 | 0.4 | 11 | ||
2019-02-07 | 2018-12-31 | -3.2 | -4.4 | -1.2 | 37 | ||
2018-12-13 | 2018-09-30 | -1.4 | -4.8 | -3.4 | 242 | ||
2018-08-13 | 2018-06-30 | -2 | -4.0 | -2.0 | 100 | ||
2018-05-03 | 2018-03-31 | -4.8 | -2.8 | 2.0 | 41 | ||
2018-02-08 | 2017-12-31 | -4.4 | -4.8 | -0.4 | 9 | ||
2017-12-15 | 2017-09-30 | -3.6 | -4.0 | -0.4 | 11 | ||
2017-08-10 | 2017-06-30 | -2.8 | -4.0 | -1.2 | 42 | ||
2017-05-11 | 2017-03-31 | -5.2 | -5.2 | 0.0 | 0 | ||
2017-02-09 | 2016-12-31 | -2.4 | -6.4 | -4.0 | 166 | ||
2016-12-06 | 2016-09-30 | -3.6 | -4.0 | -0.4 | 11 | ||
2016-08-11 | 2016-06-30 | -4.4 | -5.6 | -1.2 | 27 | ||
2016-05-12 | 2016-03-31 | -4.4 | -5.6 | -1.2 | 27 | ||
2016-02-10 | 2015-12-31 | -3.6 | -5.2 | -1.6 | 44 | ||
2015-12-14 | 2015-09-30 | -3.6 | -0.8 | 2.8 | 77 | ||
2015-08-10 | 2015-06-30 | -5.2 | -3.2 | 2.0 | 38 | ||
2015-05-11 | 2015-03-31 | -5.6 | -4.4 | 1.2 | 21 | ||
2015-02-09 | 2014-12-31 | -5.2 | -18.0 | -12.8 | 246 | ||
2011-05-16 | 2011-03-31 | -24 | -24.0 | 0.0 | 0 | ||
2010-12-15 | 2010-09-30 | -24 | -24.0 | 0.0 | 0 |
About Applied DNA Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Applied DNA earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Applied DNA estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Applied DNA fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.| Last Reported | Projected for Next Year | ||
| Retained Earnings | -278.7 M | -264.8 M | |
| Retained Earnings Total Equity | -242.9 M | -255 M | |
| Price Earnings Ratio | -141.8 K | -148.9 K | |
| Price Earnings To Growth Ratio | 1.4 K | 1.5 K |
Pair Trading with Applied DNA
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Applied DNA position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Applied DNA will appreciate offsetting losses from the drop in the long position's value.Moving against Applied Stock
| 0.95 | LASR | nLIGHT Inc | PairCorr |
| 0.9 | QUBT | Quantum Computing Downward Rally | PairCorr |
| 0.88 | QBTS | D Wave Quantum Aggressive Push | PairCorr |
| 0.86 | LITE | Lumentum Holdings | PairCorr |
| 0.82 | LPL | LG Display Earnings Call Today | PairCorr |
The ability to find closely correlated positions to Applied DNA could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Applied DNA when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Applied DNA - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Applied DNA Sciences to buy it.
The correlation of Applied DNA is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Applied DNA moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Applied DNA Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Applied DNA can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied DNA Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Electronic Equipment, Instruments & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Applied DNA. If investors know Applied will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Applied DNA listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 3.7 K | Revenue Per Share | Quarterly Revenue Growth 0.058 | Return On Assets | Return On Equity |
The market value of Applied DNA Sciences is measured differently than its book value, which is the value of Applied that is recorded on the company's balance sheet. Investors also form their own opinion of Applied DNA's value that differs from its market value or its book value, called intrinsic value, which is Applied DNA's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Applied DNA's market value can be influenced by many factors that don't directly affect Applied DNA's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Applied DNA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Applied DNA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Applied DNA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.